What it measures
Lifetime manic and hypomanic experience, in three parts. Q1 — thirteen yes/no symptom items, all under the stem “Has there ever been a period of time when you were not your usual self and …”: elevated or hyper mood, irritability, inflated self-confidence, reduced need for sleep, pressured speech, racing thoughts, distractibility, increased energy, increased activity, increased sociability, increased sexual interest, risky or excessive behaviour, and spending that caused trouble. Q2 — one yes/no question about whether several of those symptoms ever happened during the same period of time. Q3 — one four-option question about how much of a problem the symptoms caused: work, family, money, legal trouble, arguments, fights. The frame is lifetime, not the last two weeks. That’s the point — the client sitting in front of you is depressed now; the question is what happened three years ago.When to use it
- Before treating a depression as unipolar. Especially where an antidepressant is on the table or already prescribed by someone else.
- When a depression hasn’t responded as expected. Treatment-resistant depression is one of the presentations where an unrecognized bipolar-spectrum history turns up.
- Family history of bipolar disorder.
- Alongside the PHQ-9 at intake when the history includes periods the client describes as unusually good, productive, or “not myself.”
- Before a psychiatry referral, so the referral letter carries the screen rather than an impression.
How clients fill it
Two to three minutes — most of it is yes/no. The thirteen Q1 items all carry the same two options:- No
- Yes
- No problem
- Minor problem
- Moderate problem
- Serious problem
How Rivet scores it
Each Q1 item scores 1 for Yes and 0 for No, and the score Rivet shows you is the count of Yes answers across the thirteen symptom items. Range: 0–13. Q2 and Q3 carry no score. They’re captured with the response and shown with it, but they aren’t summed into anything.The positive screen
A positive MDQ screen requires all three of the following:- Seven or more Yes answers among the thirteen Q1 symptom items
- Q2 answered Yes — several of the symptoms co-occurred
- Q3 answered “Moderate problem” or “Serious problem”
Q2 and Q3 are yours to read. A Q1 of 9 with Q2 answered No, or with Q3 at
“Minor problem,” is not a positive screen — the symptoms were scattered
across the client’s life or didn’t cost them anything. Read all three
before you call it.
Hirschfeld 2000 reported sensitivity of 73% and specificity of 90% in a
psychiatric outpatient sample.
Clinical change
The MDQ isn’t a change measure. It asks about lifetime history, so re-administering it a month later measures nothing new. Administer it once, record the result, and track the depression with a depression measure.When NOT to use it
- As a diagnostic instrument. A positive screen means the clinical interview needs to cover bipolar-spectrum history properly, and usually means a psychiatry consult. It is not a diagnosis.
- To rule out bipolar disorder. A specificity of 90% is good; a sensitivity of 73% means roughly a quarter of true cases screen negative. A negative MDQ in a client with a strong family history and an odd treatment response doesn’t settle the question.
- As a repeat outcome measure. See above — the frame is lifetime.
- When the client can’t recall or report the period reliably. Collateral history often does more than the questionnaire here.
MDQ vs YMRS
The MDQ is a self-report screen about the client’s history — has there ever been a period like this. The YMRS is rated by you about the client’s state right now, and it measures how severe a current manic episode is. That makes them sequential rather than alternative. The MDQ belongs at intake, particularly before treating what looks like unipolar depression, because a missed bipolar history changes the treatment plan. The YMRS belongs after, when there is a manic or hypomanic presentation to track. One caution about the MDQ specifically: it produces more false positives in clients with borderline features or co-occurring substance use. A positive screen is a reason for a clinical interview, never a diagnosis on its own.Is it free to use?
Yes. Hirschfeld’s 2000 publication grants free reproduction without permission.Citation
Hirschfeld, Williams, Spitzer, Calabrese, Flynn, Keck, Lewis, McElroy, Post, Rapport, Russell, Sachs & Zajecka (2000). American Journal of Psychiatry, 157: 1873–1875. The MDQ carries an explicit free-reproduction licence from that publication: “this material may be reproduced without permission.” Rivet preserves the canonical item wording verbatim.Related articles
PHQ-9
The depression measure the MDQ most often accompanies at intake.
YMRS
The clinician-rated mania severity scale, for when the question moves
past screening.
Screening overview
When to screen and picking between overlapping measures.
